Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Vaughan

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 1, 2000
Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cellsK M Darcy, D Zangani, A L Wohlhueter, et al.
Breast Cancer Research and Treatment|December 1, 2001
Altered expression and localization of PKC eta in human breast tumorsP A Masso-Welch, J S Winston, S Edge, et al.
British Journal of Cancer|March 25, 2000
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancerT Eisen, C Boshoff, I Mak, et al.
The New England Journal of Medicine|October 27, 1983
Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodiesW A Valente, P Vitti, C M Rotella, et al.
The American Journal of Pathology|May 1, 1992
Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomasK Tóth, M M Vaughan, H K Slocum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase I trial in melanomaM M Vaughan, J Moore, P G Riches, et al.
European Journal of Cell Biology|September 3, 1999
Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cellsK M Darcy, A L Wohlhueter, D Zangani, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|February 1, 2000
Changes in ErbB2 (her-2/neu), ErbB3, and ErbB4 during growth, differentiation, and apoptosis of normal rat mammary epithelial cellsK M Darcy, D Zangani, A L Wohlhueter, et al.
Breast Cancer Research and Treatment|December 1, 2001
Altered expression and localization of PKC eta in human breast tumorsP A Masso-Welch, J S Winston, S Edge, et al.
British Journal of Cancer|March 25, 2000
Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancerT Eisen, C Boshoff, I Mak, et al.
The New England Journal of Medicine|October 27, 1983
Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodiesW A Valente, P Vitti, C M Rotella, et al.
The American Journal of Pathology|May 1, 1992
Comparison of an immunoperoxidase "sandwich" staining method and western blot detection of P-glycoprotein in human cell lines and sarcomasK Tóth, M M Vaughan, H K Slocum, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 4, 2000
GM-CSF with biochemotherapy (cisplatin, DTIC, tamoxifen, IL-2 and interferon-alpha): a phase I trial in melanomaM M Vaughan, J Moore, P G Riches, et al.
European Journal of Cell Biology|September 3, 1999
Selective changes in EGF receptor expression and function during the proliferation, differentiation and apoptosis of mammary epithelial cellsK M Darcy, A L Wohlhueter, D Zangani, et al.
Pageof 2